Search is Powered by Google
Pharma Industry / Biotech Industry News

Action Plan Proposed To Boost Students' In Vivo Skills, UK

Main Category: Pharma Industry / Biotech Industry
Also Included In: Medical Students / Training
Article Date: 04 Oct 2007 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

An action plan to encourage students to develop skills in animal research is proposed in a joint report from the Biosciences Federation and the Association of the British Pharmaceutical Industry (ABPI), launched recently.

As well as helping the UK maintain its leadership in medicines discovery and development, such skills are essential in reducing, refining and replacing animals in such work.

The action plan - necessary because of a growing difficulty in finding staff with appropriate in vivo skills - calls for measures to raise student interest in developing such skills as well as a joint drive to provide employer-focused post-graduate degrees.

"The future of medicines development in this country depends to a large extent on having people with the right in vivo skills. Significant progress has already been made through joint public and private sector working, and we all need to work in partnership so that the UK can retain its historical strengths in this area," said Dr Richard Barker, Director General of the ABPI.

Dr Richard Dyer, Chief Executive of the Biosciences Federation, said: "As well as creating a targeted package of employer-led action to support existing initiatives, the underlying factors behind the decline in numbers need to be tackled. Success in the long term will depend on the scientific community recognising that in vivo techniques are not just an optional 'add-on' at the end of a scientific process."

The report shows that employer demand for these skills has been stable over the past 10 years, but supply has declined. Three-quarters of relevant employers - universities, public sector, charity research organisations and the pharmaceutical industry - are finding it "difficult" or "very difficult" to find suitably qualified staff.

The report recommends that:

The overall number of employer placements with in vivo work is increased by at least 50 per cent.
Some 36 MSc places are fully funded over the next three years to provide exposure to in vivo techniques.
The number of PhDs that use in vivo techniques is increased.

Sub-disciplines that include in vivo techniques - pharmacology, physiology, toxicology and pathology - should be recognised as Strategically Important and Vulnerable Subjects, a formal Government classification that recognises their importance to the economy and society but recognises their vulnerability because of low student demand.

The investigation was facilitated by the former Department of Trade and Industry, which has been replaced by the Department for Business Enterprise and Regulatory Reform (BERR) and the Department for Innovation, Universities and Skills (DIUS).

The report, In vivo sciences in the UK: sustaining the supply of skills in the 21st century, can be downloaded from the ABPI website

Association of the British Pharmaceutical Industry




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Sanofi Aventis Invests 100 Million Euros In New Facility In Mexico To Produce Seasonaland Pandemic Influenza Vaccine
19 Mar 2009
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY), announced the signing of an agreement with the Mexican authorities to build a 100 million euro facility to manufacture influenza vaccine in Mexico...


LASIK Surgery - Trading in Lenses for Laser
LASIK Surgery - Trading in Lenses for Laser

For millions of Americans, LASIK ends years of dependence on glasses and contact lenses. But there are risks, and the surgical procedure is not for everyone.

more videos are available in our health videos section.